1.
Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
by Domingueti, Caroline Pereira
Journal of diabetes and its complications, 2015, Vol.30 (4), p.738-745
2.
The many faces of diabetes: a disease with increasing heterogeneity
by Tuomi, Tiinamaija, MD
The Lancet (British edition), 2014, Vol.383 (9922), p.1084-1094
3.
Molecular mechanisms of diabetic cardiomyopathy
by Bugger, Heiko
Diabetologia, 2014, Vol.57 (4), p.660-671
4.
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
by Eid, Stephanie
Diabetologia, 2019, Vol.62 (9), p.1539-1549
5.
Development of SGLT1 and SGLT2 inhibitors
by Rieg, Timo
Diabetologia, 2018, Vol.61 (10), p.2079-2086
6.
Early prediction of autoimmune (type 1) diabetes
by Regnell, Simon E
Diabetologia, 2017, Vol.60 (8), p.1370-1381
7.
Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes
by Musso, Giovanni
Annual review of medicine, 2011, Vol.62 (1), p.361-380
8.
Type 2 diabetes: a multifaceted disease
by Pearson, Ewan R
Diabetologia, 2019, Vol.62 (7), p.1107-1112
9.
Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice
by Vegas, Arturo J
Nature medicine, 2016, Vol.22 (3), p.306-311
10.
Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities
by Sivitz, William I.
Antioxidants & redox signaling, 2010, Vol.12 (4), p.537-577
11.
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
by Vallon, Volker
Annual review of medicine, 2015, Vol.66 (1), p.255-270
12.
Toll-like receptors regulate B cell cytokine production in patients with diabetes
by Jagannathan, M
Diabetologia, 2010, Vol.53 (7), p.1461-1471
13.
Immunological biomarkers for the development and progression of type 1 diabetes
by Mathieu, Chantal
Diabetologia, 2018, Vol.61 (11), p.2252-2258
14.
Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis
by Perry, Rachel J
Nature medicine, 2014, Vol.20 (7), p.759-763
15.
Insulitis in human diabetes: a histological evaluation of donor pancreases
by Lundberg, Marcus
Diabetologia, 2016, Vol.60 (2), p.346-353
16.
Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
by Richardson, Sarah J
Diabetologia, 2016, Vol.59 (11), p.2448-2458
17.
Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
by Murphy, Helen R
Diabetologia, 2019, Vol.62 (7), p.1123-1128
18.
Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes
by Lakhter, Alexander J
Diabetologia, 2018, Vol.61 (5), p.1124-1134
19.
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
by Hope, Suzy V
Diabetologia, 2017, Vol.61 (1), p.66-74
20.
Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes
by Andersen, Mette K
Diabetologia, 2014, Vol.57 (9), p.1859-1868
